Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 (Related Reports)

Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017


June 1, 2011
65 Pages - SKU: GBDT6505603
License type:
Online Download      US $2,000.00
Global Site License      US $6,000.00
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This  |  read more...
$2,500.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Pertussis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Pertussis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2014’, provides an overview of the Pertussis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative  |  read more...
$2,000.00
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014’, provides an overview of the Klebsiella Pneumoniae Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Polio - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polio - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polio - Pipeline Review, H1 2014’, provides an overview of the Polio’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polio, complete with comparative  |  read more...
$2,000.00
Typhoid Fever - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Typhoid Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid  |  read more...
$2,000.00
Perennial Allergic Rhinitis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Perennial Allergic Rhinitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H1 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Severe Psoriasis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Severe Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Severe  |  read more...
$2,000.00
Yellow Fever - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Yellow Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H1 2014’, provides an overview of the Yellow Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Yellow  |  read more...
$2,000.00